Victoza vs Ozempic: Weight Loss & Differences

Victoza vs Ozempic comes down to two GLP-1 medicines from Novo Nordisk that treat the same condition on very different schedules. Victoza (liraglutide) is a daily injection, while Ozempic (semaglutide) is a once-weekly injection. Both are FDA-approved for type 2 diabetes, not weight loss, but semaglutide (Ozempic) generally produces more weight loss and stronger blood sugar control than liraglutide (Victoza).

If your clinician has mentioned both drugs, or you have seen them compared online, it helps to understand what actually separates them. They belong to the same drug class and are made by the same company, yet they are not interchangeable. This guide walks through the active ingredients, dosing, effectiveness, side effects, and the weight-management versions of each.

The quick version of Victoza vs Ozempic

Both Victoza and Ozempic are GLP-1 receptor agonists. GLP-1 is a hormone your gut releases after you eat. These medicines copy its effect: they prompt the pancreas to release insulin when blood sugar is high, slow how fast the stomach empties, and reduce appetite. That combination is why both drugs lower blood sugar and can lead to weight loss as a side effect. You can read more about the underlying biology in our guide to how semaglutide works for weight loss.

The single biggest practical difference is how long each drug stays active in the body. Liraglutide (Victoza) has a half-life of about a day, so it has to be injected once every day. Semaglutide (Ozempic) has a half-life of about a week, so a single weekly injection keeps working the whole time. That difference in chemistry drives almost everything else, including convenience and, to a large extent, effectiveness.

Side-by-side comparison

Feature	Victoza	Ozempic
Active ingredient	Liraglutide	Semaglutide
Dosing frequency	Once daily	Once weekly
Doses	0.6 mg, then 1.2 mg, up to 1.8 mg	0.25 mg starter, 0.5 mg, 1 mg, up to 2 mg
FDA-approved use	Type 2 diabetes	Type 2 diabetes
Weight loss	Modest; less than Ozempic	Greater than Victoza
Weight-approved twin	Saxenda (liraglutide)	Wegovy (semaglutide)

Dosing and convenience

Victoza starts at 0.6 mg once daily, mainly to let your body adjust and limit nausea. After about a week it usually moves to 1.2 mg, and it can go up to 1.8 mg once daily. Because it is a daily injection, you are giving yourself seven shots a week.

Ozempic starts at 0.25 mg once weekly as a non-therapeutic starter dose, then steps up to 0.5 mg, then 1 mg, and can reach 2 mg once weekly. That is a single injection per week. For many people, the difference between one shot a week and seven shots a week is a meaningful factor in choosing a treatment and sticking with it. Weekly Ozempic is generally more convenient than daily Victoza.

Effectiveness: is Ozempic better than Victoza for weight loss?

In head-to-head research, semaglutide tends to outperform liraglutide. The SUSTAIN-10 trial compared once-weekly semaglutide 1 mg against once-daily liraglutide 1.2 mg in adults with type 2 diabetes. Semaglutide lowered A1c more and produced greater body weight reduction than liraglutide. In practical terms, Ozempic tends to produce more weight loss than Victoza, and it tends to control blood sugar somewhat better.

That said, neither drug is approved by the FDA for weight loss. Any weight change with Victoza or Ozempic is a secondary effect of treating diabetes. If weight is the primary goal, the on-label options are the weight-management versions of these same molecules, covered below. For a broader look at how different medicines stack up, see our roundup of GLP-1 weight loss results by drug.

Side effects and safety

Because Victoza and Ozempic share a mechanism, they share a side effect profile. The most common issues are gastrointestinal: nausea, diarrhea, vomiting, and constipation. These tend to be concentrated early in treatment and during dose increases, then often ease as the body adjusts. Starting low and stepping up slowly is designed to reduce these effects. Our detailed page on Ozempic side effects applies broadly to both drugs.

Both medicines carry a boxed warning about thyroid C-cell tumors based on animal studies, so they are not recommended for people with a personal or family history of medullary thyroid carcinoma or the syndrome MEN 2. The risk of low blood sugar (hypoglycemia) is generally low on their own, but it rises when either drug is combined with insulin or a sulfonylurea, and dosing of those other medicines may need adjusting. None of this replaces a conversation with your prescriber, who will weigh your full medical history.

What about the weight-loss versions?

Here is where people often get confused. Victoza and Ozempic each have a sibling that is FDA-approved specifically for weight management, using the same active ingredient at a different dose.

• Saxenda is higher-dose liraglutide, the same molecule as Victoza, approved for chronic weight management.
• Wegovy is higher-dose semaglutide, the same molecule as Ozempic, approved for chronic weight management.

So if your goal is weight loss specifically, the on-label choices are Wegovy and Saxenda rather than Ozempic or Victoza. To compare the weight drugs directly, see Ozempic vs Wegovy and Saxenda vs Wegovy. You can also review the full list of FDA-approved GLP-1 medications to see where each product fits.

Which one is right for you?

There is no single winner. Ozempic offers weekly dosing and generally stronger results, which many people prefer. Victoza remains a well-established daily option, and some treatment plans, insurance situations, or individual responses point toward it. The right choice depends on your diabetes management, weight goals, tolerance for side effects, insurance coverage, and preferences, all of which a clinician can help sort out. If you want a deeper primer on the semaglutide side of this comparison, our semaglutide explained guide goes further.